Amino Acids For cGMP Biopharmaceutical Manufacturing

A passing specification does not settle whether an amino acid is right for a regulated process. Two materials with similar analytical profiles can rest on very different manufacturing, quality, and supply systems, and responsibility for judging suitability stays with the manufacturer using them.

This article looks at how cGMP differs from a product label, why intended use should drive specification-setting, and where a Certificate of Analysis fits within a broader documentation strategy. It also considers supplier qualification, lot traceability, and change notification, and closes with four questions for evaluating a material before approval. Written with quality, process-development, manufacturing, and procurement teams in mind, it frames sourcing as part of the control strategy.

Read on to see how those questions apply to your own raw-material decisions.